Inhibitory effects of green tea on carcinogenesis have been investigated in numerous laboratory studies using (-) - epigallocatechin gallate (EGCG) or crude green tea extract, and there is also some epidemiologic evidence.
Further, EGCG has been reported to inhibit the growth of cancer cells, lung metastasis in an animal model, and urokinase activity.
In this study, we first examined the association between consumption of green tea prior to clinical cancer onset and various clinical parameters assessed at surgery among 472 patients with stage I, II, and III breast cancer.
We found that increased consumption of green tea was closely associated with decreased numbers of axillary lymph node metastases among premenopausal patients with stage I and II breast cancer and with increased expression of progesterone receptor (PgR) and estrogen receptor (ER) among postmenopausal ones.
Since these are potential prognostic factors, we then investigated the prognosis of breast cancer with special reference to consumption of green tea, in a follow-up study of these patients.
We found that increased consumption of green tea was correlated with decreased recurrence of stage I and II breast cancer (P<0.05 for crude disease-free survival) ; the recurrence rate was 16.7 or 24.3% among those consuming =5 cups or ¾4 cups per day, respectively, in a seven-year follow-up of stage I and II breast cancer, and the relative risk of recurrence was 0.564 (95% confidence interval, 0.350-0. (...)
Mots-clés Pascal : Tumeur maligne, Glande mammaire, Thé vert, Mode de vie, Epidémiologie, Pronostic, Japon, Asie, Homme, Glande mammaire pathologie
Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Green tea, Life habit, Epidemiology, Prognosis, Japan, Asia, Human, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0236628
Code Inist : 002B20E02. Création : 11/09/1998.